Insights into the Industry
The nuclear medicine industry has been witnessing optimal growth in recent years and is likely to continue even in upcoming years. The growth of nuclear medicine ’s industry size can be attributed to rising investments in research & development activities, entry of new players, product innovation, technological breakthroughs, effective allocation of resources, and growing competition among business rivals to expand its regional as well as customer base. Supportive government policies and incentives, as well as favorable laws, are projected to determine the growth of the nuclear medicine market in foreseeable future. An increase in the spending capacity of customers with the rise in disposable income will further contribute towards nuclear medicine 's market proceeds.
This market research report is a comprehensive overview of the events taking place in the nuclear medicine industry and impacting its growth. Our report divides the nuclear medicine market into various segments or categories based on products, applications, region, etc. Additionally, our research analysts have listed the key players of the global nuclear medicine market and compared them based on metrics such as market revenue, Y-O-Y sales, shipments volume, historical data, and successful implementation of business strategies such as strategic alliances, mergers & acquisitions, joint ventures, product development, and partnerships & collaborations.
Market Research Store (MRS) published a brand new report titled “Nuclear Medicine Market research report which is segmented by Products (Therapeutic, Diagnostic), by Applications (Cardiology, Neurology, Oncology, Thyroid, Others), by Key Players/Companies Cardinal Health, Lantheus Medical Imaging, Nordion Inc., Eczcibasi-Monrol Nuclear Products, GE Healthcare, IBA Molecular Imaging, Siemens Healthcare, Ashby Gorman Baker Ltd, Philips Healthcare, Advanced Accelerator Applications S.A., Digirad, Mediso Ltd., Bayer Healthcare, Mallinckrodt PLC, Bracco Imaging S.P.A”. In 2020, the global nuclear medicine market value was registered at XX (USD Million/Billion) and is predicted to reach XX (USD Million/Billion) at a CAGR of XX% by 2028.
Request Free SampleScope of the report
| Report Attributes | Report Details |
|---|---|
| Report Title | Nuclear Medicine Market Research Report |
| By Products | Therapeutic, Diagnostic |
| By Applications | Cardiology, Neurology, Oncology, Thyroid, Others |
| By Key Players | Cardinal Health, Lantheus Medical Imaging, Nordion Inc., Eczcibasi-Monrol Nuclear Products, GE Healthcare, IBA Molecular Imaging, Siemens Healthcare, Ashby Gorman Baker Ltd, Philips Healthcare, Advanced Accelerator Applications S.A., Digirad, Mediso Ltd., Bayer Healthcare, Mallinckrodt PLC, Bracco Imaging S.P.A |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East And Africa (MEA) |
| Countries Covered | North America : U.S and Canada Europe : U.K, Spain, Germany, Italy, Russia, France, Rest of Europe APAC : Japan, India, China, Australia, South Korea, South East Asia, Rest of Asia Pacific Latin America : Mexico, Brazil The Middle East And Africa : South Africa, UAE, Saudi Arab, Rest of MEA |
| Base Year | 2020 |
| Historical Year | 2016to 2020 (Depending on availability, data from 2010 can be offered) |
| Forecast Year | 2028 |
| Number of Pages | 109 |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Based on these findings, the global nuclear medicine industry study suggests strategies to existing market participants as to how they can improve & reinforce their market position. In addition to this, the study also recommends successful market penetrating strategies for new entrants. Furthermore, nuclear medicine industry study report has included all major manufacturers and distributors operating in the nuclear medicine market across all major regions.
Nuclear Medicine Market Strategic Analysis
Various analytical methods such as Porter’s Five Force Analysis, SWOT analysis, Market Share Analysis, Competitive Analysis, PESTEL Analysis, Market Attractiveness Analysis, and Value Chain Analysis have been used to analyze the market in the research report. These assessments help users of the report in examining and evaluating nuclear medicine market on the basis of different metrics such as switching costs, economies of scale, current sales, brand loyalty, brand equity, capital investments, production rights, research & development activities, copyrights & patents, legislations, effects of promotional activities, and consumer preferences.
The information provided in our market research report is anticipated to help the industry stakeholders in the effective decision-making process and successful business outcomes. Moreover, we have been using Ansoff Matrix to help firms analyze and plan their business growth strategies.
Additionally, our report contains a growth-share matrix that aids firms’ business decisions for prioritizing their myriad businesses. We have also included GE Nine Cell Matrix that is helpful in making strategic planning and can help firms in determining their position in the market along with analyzing their growth strategies.
Our researchers also make use of the perceptual map to demonstrate how to target consumers feel about a given brand and form perception about it. We have also included the Customer-Based Brand Equity (CBBE) Model for helping firms effectively position their brands.
Nuclear Medicine Market Key Trends Analysis
The key factors influencing the growth of the nuclear medicine market have been assessed in the report. Factors having a huge influence on market demand and restraining factors that impact the development of the market are both addressed rigorously & in-depth in our global market research report.
Furthermore, trends that play a key role in market’s growth are discussed comprehensively in the report. Moreover, a large number of qualitative factors or measurements are included in the report and this includes operating risks and major obstacles encountered by players in the industry.
Nuclear Medicine Market Key Segment Analysis
The report delivers a critical assessment on the nuclear medicine market by segmenting it based on Products, Applications, and region. All the segments and categories of the nuclear medicine market have been evaluated based on past, present and future trends and are key parameters determining & defining the growth of the market.
The data for the market and its segments and categories are provided from 2016 to 2028. The report has identified the key segments and categories contributing substantially towards overall market growth in terms of revenue & volume.
Based on Products, the global nuclear medicine market is segmented into Therapeutic, Diagnostic. Comprehensive qualitative and quantitative this segment analysis will be provided in the report from 2016 to 2028.
Based on Applications, market is divided into Cardiology, Neurology, Oncology, Thyroid, Others. A slew of business growth opportunities and dynamics affecting the different segments are analyzed and discussed in the report.
Impact Assessment of COVID-19
The COVID-19 outbreak has wreaked havoc on worldwide economic and social systems. The disease has entered several industries' value and supply chains, including the nuclear medicine market. The government imposed lockdowns in various locations. We will examine the impact of the COVID-19 pandemic on the global market, looking at both demand and supply.
The COVID-19 pandemic's short- and long-term impacts would be explored to provide a summary. This would help build business plans for all market participants, including manufacturers, vendors, suppliers, distributors, and end-users, during and after the epidemic.
Nuclear Medicine Market Regional Trends and Market Player’s Analysis
On the basis of region, the market is segregated into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa.
The major players holding a huge chunk of market share in the global nuclear medicine market and impacting market profitability are evaluated after considering their product & services revenue, sales, business plans, innovations, and growth rate. The final position of a player in the market depends on market events or market happenings, new product launches, mergers & acquisitions, benchmarking, regional expansions, and technical innovations.
For all the key stakeholders of the market, value chain and technology ecosystem, as well as the information provided in this market research report, will prove beneficial. The study offers an outline of the company’s market share and an extensive summary of the major players in the nuclear medicine market.
Some of the leading players profiled in the global nuclear medicine market are,
- Cardinal Health
- Lantheus Medical Imaging
- Nordion Inc.
- Eczcibasi-Monrol Nuclear Products
- GE Healthcare
- IBA Molecular Imaging
- Siemens Healthcare
- Ashby Gorman Baker Ltd
- Philips Healthcare
- Advanced Accelerator Applications S.A.
- Digirad
- Mediso Ltd.
- Bayer Healthcare
- Mallinckrodt PLC
- Bracco Imaging S.P.A
The Key Audiences for Nuclear Medicine Market Report
- Research Institutes & consulting firms
- Industry Leaders, as well as companies, aspiring to enter the nuclear medicine market
- Student and universities
- Solution Providers, product providers, service providers, and other players in the industry
- Associated private firms and government bodies
- Individuals interested to learn about market
The report segments of the global nuclear medicine market are as follows:
Global Nuclear Medicine Market: By Products
- Therapeutic
- Diagnostic
Global Nuclear Medicine Market: By Applications
- Cardiology
- Neurology
- Oncology
- Thyroid
- Others
The Most Important Research Methodologies
Primary sources include industry experts from management corporations, processing organizations, and analytical service providers who serve businesses across the sector's value chain. We interviewed key sources to acquire qualitative and quantitative data and analyse future prospects.
Primary research undertaken for this report comprised interviews with industry professionals such as CEOs, Vice Presidents, Marketing Directors and Technology Directors of strong core organizations and institutions in major nuclear medicine . We interviewed them to get qualitative and quantitative data.
The following are the justifications for purchasing the global Nuclear Medicine market report:
- Statistical data is well-referenced, and the source is a significant resource for directing interested companies.
- Market development trends and marketing channels that are cutting-edge are discussed.
- The feasibility and growth rate of the market as a whole over the foreseeable future are determined.
- The competitive landscape and demographic research provide a clear picture of the current state of the market on an international scale.
- A thorough examination of development policies and plans, manufacturing processes, and costing provides a more accurate picture of import/export consumption, supply and demand, pricing, revenue, and gross margins, among other things.
- Customization is possible based on the client's requirements.
Frequently Asked Questions
- Cardinal Health
- Lantheus Medical Imaging
- Nordion Inc.
- Eczcibasi-Monrol Nuclear Products
- GE Healthcare
- IBA Molecular Imaging
- Siemens Healthcare
- Ashby Gorman Baker Ltd
- Philips Healthcare
- Advanced Accelerator Applications S.A.
- Digirad
- Mediso Ltd.
- Bayer Healthcare
- Mallinckrodt PLC
- Bracco Imaging S.P.A
Table Of Content
Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Nuclear Medicine Market Share by Type (2020-2026) 1.5.2 Therapeutic 1.5.3 Diagnostic 1.6 Market by Application 1.6.1 Global Nuclear Medicine Market Share by Application (2020-2026) 1.6.2 Cardiology 1.6.3 Neurology 1.6.4 Oncology 1.6.5 Thyroid 1.6.6 Others 1.7 Nuclear Medicine Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Nuclear Medicine Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of Nuclear Medicine Market 3.1 Value Chain Status 3.2 Nuclear Medicine Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Nuclear Medicine 3.2.3 Labor Cost of Nuclear Medicine 3.2.3.1 Labor Cost of Nuclear Medicine Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 Cardinal Health 4.1.1 Cardinal Health Basic Information 4.1.2 Nuclear Medicine Product Profiles, Application and Specification 4.1.3 Cardinal Health Nuclear Medicine Market Performance (2015-2020) 4.1.4 Cardinal Health Business Overview 4.2 Lantheus Medical Imaging 4.2.1 Lantheus Medical Imaging Basic Information 4.2.2 Nuclear Medicine Product Profiles, Application and Specification 4.2.3 Lantheus Medical Imaging Nuclear Medicine Market Performance (2015-2020) 4.2.4 Lantheus Medical Imaging Business Overview 4.3 Nordion, Inc. 4.3.1 Nordion, Inc. Basic Information 4.3.2 Nuclear Medicine Product Profiles, Application and Specification 4.3.3 Nordion, Inc. Nuclear Medicine Market Performance (2015-2020) 4.3.4 Nordion, Inc. Business Overview 4.4 Eczcibasi-Monrol Nuclear Products 4.4.1 Eczcibasi-Monrol Nuclear Products Basic Information 4.4.2 Nuclear Medicine Product Profiles, Application and Specification 4.4.3 Eczcibasi-Monrol Nuclear Products Nuclear Medicine Market Performance (2015-2020) 4.4.4 Eczcibasi-Monrol Nuclear Products Business Overview 4.5 GE Healthcare 4.5.1 GE Healthcare Basic Information 4.5.2 Nuclear Medicine Product Profiles, Application and Specification 4.5.3 GE Healthcare Nuclear Medicine Market Performance (2015-2020) 4.5.4 GE Healthcare Business Overview 4.6 IBA Molecular Imaging 4.6.1 IBA Molecular Imaging Basic Information 4.6.2 Nuclear Medicine Product Profiles, Application and Specification 4.6.3 IBA Molecular Imaging Nuclear Medicine Market Performance (2015-2020) 4.6.4 IBA Molecular Imaging Business Overview 4.7 Siemens Healthcare 4.7.1 Siemens Healthcare Basic Information 4.7.2 Nuclear Medicine Product Profiles, Application and Specification 4.7.3 Siemens Healthcare Nuclear Medicine Market Performance (2015-2020) 4.7.4 Siemens Healthcare Business Overview 4.8 Ashby Gorman Baker Ltd 4.8.1 Ashby Gorman Baker Ltd Basic Information 4.8.2 Nuclear Medicine Product Profiles, Application and Specification 4.8.3 Ashby Gorman Baker Ltd Nuclear Medicine Market Performance (2015-2020) 4.8.4 Ashby Gorman Baker Ltd Business Overview 4.9 Philips Healthcare 4.9.1 Philips Healthcare Basic Information 4.9.2 Nuclear Medicine Product Profiles, Application and Specification 4.9.3 Philips Healthcare Nuclear Medicine Market Performance (2015-2020) 4.9.4 Philips Healthcare Business Overview 4.10 Advanced Accelerator Applications S.A. 4.10.1 Advanced Accelerator Applications S.A. Basic Information 4.10.2 Nuclear Medicine Product Profiles, Application and Specification 4.10.3 Advanced Accelerator Applications S.A. Nuclear Medicine Market Performance (2015-2020) 4.10.4 Advanced Accelerator Applications S.A. Business Overview 4.11 Digirad 4.11.1 Digirad Basic Information 4.11.2 Nuclear Medicine Product Profiles, Application and Specification 4.11.3 Digirad Nuclear Medicine Market Performance (2015-2020) 4.11.4 Digirad Business Overview 4.12 Mediso Ltd. 4.12.1 Mediso Ltd. Basic Information 4.12.2 Nuclear Medicine Product Profiles, Application and Specification 4.12.3 Mediso Ltd. Nuclear Medicine Market Performance (2015-2020) 4.12.4 Mediso Ltd. Business Overview 4.13 Bayer Healthcare 4.13.1 Bayer Healthcare Basic Information 4.13.2 Nuclear Medicine Product Profiles, Application and Specification 4.13.3 Bayer Healthcare Nuclear Medicine Market Performance (2015-2020) 4.13.4 Bayer Healthcare Business Overview 4.14 Mallinckrodt PLC 4.14.1 Mallinckrodt PLC Basic Information 4.14.2 Nuclear Medicine Product Profiles, Application and Specification 4.14.3 Mallinckrodt PLC Nuclear Medicine Market Performance (2015-2020) 4.14.4 Mallinckrodt PLC Business Overview 4.15 Bracco Imaging S.P.A 4.15.1 Bracco Imaging S.P.A Basic Information 4.15.2 Nuclear Medicine Product Profiles, Application and Specification 4.15.3 Bracco Imaging S.P.A Nuclear Medicine Market Performance (2015-2020) 4.15.4 Bracco Imaging S.P.A Business Overview 5 Global Nuclear Medicine Market Analysis by Regions 5.1 Global Nuclear Medicine Sales, Revenue and Market Share by Regions 5.1.1 Global Nuclear Medicine Sales by Regions (2015-2020) 5.1.2 Global Nuclear Medicine Revenue by Regions (2015-2020) 5.2 North America Nuclear Medicine Sales and Growth Rate (2015-2020) 5.3 Europe Nuclear Medicine Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Nuclear Medicine Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Nuclear Medicine Sales and Growth Rate (2015-2020) 5.6 South America Nuclear Medicine Sales and Growth Rate (2015-2020) 6 North America Nuclear Medicine Market Analysis by Countries 6.1 North America Nuclear Medicine Sales, Revenue and Market Share by Countries 6.1.1 North America Nuclear Medicine Sales by Countries (2015-2020) 6.1.2 North America Nuclear Medicine Revenue by Countries (2015-2020) 6.1.3 North America Nuclear Medicine Market Under COVID-19 6.2 United States Nuclear Medicine Sales and Growth Rate (2015-2020) 6.2.1 United States Nuclear Medicine Market Under COVID-19 6.3 Canada Nuclear Medicine Sales and Growth Rate (2015-2020) 6.4 Mexico Nuclear Medicine Sales and Growth Rate (2015-2020) 7 Europe Nuclear Medicine Market Analysis by Countries 7.1 Europe Nuclear Medicine Sales, Revenue and Market Share by Countries 7.1.1 Europe Nuclear Medicine Sales by Countries (2015-2020) 7.1.2 Europe Nuclear Medicine Revenue by Countries (2015-2020) 7.1.3 Europe Nuclear Medicine Market Under COVID-19 7.2 Germany Nuclear Medicine Sales and Growth Rate (2015-2020) 7.2.1 Germany Nuclear Medicine Market Under COVID-19 7.3 UK Nuclear Medicine Sales and Growth Rate (2015-2020) 7.3.1 UK Nuclear Medicine Market Under COVID-19 7.4 France Nuclear Medicine Sales and Growth Rate (2015-2020) 7.4.1 France Nuclear Medicine Market Under COVID-19 7.5 Italy Nuclear Medicine Sales and Growth Rate (2015-2020) 7.5.1 Italy Nuclear Medicine Market Under COVID-19 7.6 Spain Nuclear Medicine Sales and Growth Rate (2015-2020) 7.6.1 Spain Nuclear Medicine Market Under COVID-19 7.7 Russia Nuclear Medicine Sales and Growth Rate (2015-2020) 7.7.1 Russia Nuclear Medicine Market Under COVID-19 8 Asia-Pacific Nuclear Medicine Market Analysis by Countries 8.1 Asia-Pacific Nuclear Medicine Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Nuclear Medicine Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Nuclear Medicine Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific Nuclear Medicine Market Under COVID-19 8.2 China Nuclear Medicine Sales and Growth Rate (2015-2020) 8.2.1 China Nuclear Medicine Market Under COVID-19 8.3 Japan Nuclear Medicine Sales and Growth Rate (2015-2020) 8.3.1 Japan Nuclear Medicine Market Under COVID-19 8.4 South Korea Nuclear Medicine Sales and Growth Rate (2015-2020) 8.4.1 South Korea Nuclear Medicine Market Under COVID-19 8.5 Australia Nuclear Medicine Sales and Growth Rate (2015-2020) 8.6 India Nuclear Medicine Sales and Growth Rate (2015-2020) 8.6.1 India Nuclear Medicine Market Under COVID-19 8.7 Southeast Asia Nuclear Medicine Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia Nuclear Medicine Market Under COVID-19 9 Middle East and Africa Nuclear Medicine Market Analysis by Countries 9.1 Middle East and Africa Nuclear Medicine Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Nuclear Medicine Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Nuclear Medicine Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa Nuclear Medicine Market Under COVID-19 9.2 Saudi Arabia Nuclear Medicine Sales and Growth Rate (2015-2020) 9.3 UAE Nuclear Medicine Sales and Growth Rate (2015-2020) 9.4 Egypt Nuclear Medicine Sales and Growth Rate (2015-2020) 9.5 Nigeria Nuclear Medicine Sales and Growth Rate (2015-2020) 9.6 South Africa Nuclear Medicine Sales and Growth Rate (2015-2020) 10 South America Nuclear Medicine Market Analysis by Countries 10.1 South America Nuclear Medicine Sales, Revenue and Market Share by Countries 10.1.1 South America Nuclear Medicine Sales by Countries (2015-2020) 10.1.2 South America Nuclear Medicine Revenue by Countries (2015-2020) 10.1.3 South America Nuclear Medicine Market Under COVID-19 10.2 Brazil Nuclear Medicine Sales and Growth Rate (2015-2020) 10.2.1 Brazil Nuclear Medicine Market Under COVID-19 10.3 Argentina Nuclear Medicine Sales and Growth Rate (2015-2020) 10.4 Columbia Nuclear Medicine Sales and Growth Rate (2015-2020) 10.5 Chile Nuclear Medicine Sales and Growth Rate (2015-2020) 11 Global Nuclear Medicine Market Segment by Types 11.1 Global Nuclear Medicine Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Nuclear Medicine Sales and Market Share by Types (2015-2020) 11.1.2 Global Nuclear Medicine Revenue and Market Share by Types (2015-2020) 11.2 Therapeutic Sales and Price (2015-2020) 11.3 Diagnostic Sales and Price (2015-2020) 12 Global Nuclear Medicine Market Segment by Applications 12.1 Global Nuclear Medicine Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Nuclear Medicine Sales and Market Share by Applications (2015-2020) 12.1.2 Global Nuclear Medicine Revenue and Market Share by Applications (2015-2020) 12.2 Cardiology Sales, Revenue and Growth Rate (2015-2020) 12.3 Neurology Sales, Revenue and Growth Rate (2015-2020) 12.4 Oncology Sales, Revenue and Growth Rate (2015-2020) 12.5 Thyroid Sales, Revenue and Growth Rate (2015-2020) 12.6 Others Sales, Revenue and Growth Rate (2015-2020) 13 Nuclear Medicine Market Forecast by Regions (2020-2026) 13.1 Global Nuclear Medicine Sales, Revenue and Growth Rate (2020-2026) 13.2 Nuclear Medicine Market Forecast by Regions (2020-2026) 13.2.1 North America Nuclear Medicine Market Forecast (2020-2026) 13.2.2 Europe Nuclear Medicine Market Forecast (2020-2026) 13.2.3 Asia-Pacific Nuclear Medicine Market Forecast (2020-2026) 13.2.4 Middle East and Africa Nuclear Medicine Market Forecast (2020-2026) 13.2.5 South America Nuclear Medicine Market Forecast (2020-2026) 13.3 Nuclear Medicine Market Forecast by Types (2020-2026) 13.4 Nuclear Medicine Market Forecast by Applications (2020-2026) 13.5 Nuclear Medicine Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data Source
Inquiry For Buying
Nuclear Medicine
Request Sample
Nuclear Medicine
